0 items

in your cart
$0.00

  • Search for Medications
  • Viewcart | Checkout
  • Manage Account
  •  
  • Click-to-Call  

Prescription Drug Search

Strengths available for Rimonabant :

Search for a drug:

 

Browse Alphabetically:

A · B · C · D · E · F · G · H · I · J · K · L · M · N
O · P · Q · R · S · T · U · V · W · X · Y · Z · #

Information about GlobalPharmacyMeds.to

SSL Secured Website Certified Global Pharmacy Network Hacker Proof: Safe Shopping Experience 5th Anniversary 2002-2007

List of countries where we can ship Rimonabant:

  • Antigua and Barbuda
  • Aruba
  • Azerbaijan
  • Barbados
  • Bulgaria
  • Chile
  • China
  • Colombia
  • Costa Rica
  • Finland
  • France
  • Germany
  • Grenada
  • Honduras
  • Iceland
  • India
  • Indonesia
  • Italy
  • Jamaica
  • Latvia
  • Lithuania
  • Luxembourg
  • Morocco
  • Netherlands Antilles
  • Nicaragua
  • Panama
  • Paraguay
  • Poland
  • Portugal
  • Romania
  • Serbia
  • Singapore
  • South Africa
  • Sri Lanka
  • Tonga
  • Trinidad and Tobago
  • Tunisia
  • United Kingdom, UK
  • United States, US
  • Vanuatu
View All Countries

Latest news releases on Rimonabant:

Rimonabant - Wikipedia

Rimonabant (also known as SR141716; trade names Acomplia, Zimulti) is an anorectic antiobesity drug that was first approved in Europe in 2006 but was withdrawn ...

Acomplia: Uses, Dosage, Side Effects & Warnings - Drugs.com

Sanofi-Aventis has withdrawn rimonabant from the market globally and it is no longer under development. 1 Acomplia was officially withdrawn by the European Medicines ...

Rimonabant - an overview | ScienceDirect Topics

Atrial fibrillation has been attributed to rimonabant in two cases [114 A]. • A man who took rimonabant for 5 weeks developed palpitation, fatigue, and exertional ...

Rimonabant | C22H21Cl3N4O - PubChem - The PubChem Project

Rimonabant is an anorectic anti-obesity drug produced and marketed by Sanofi-Aventis. It is an inverse agonist for the cannabinoid receptor CB1.

Rimonabant – Wikipedia

Rimonabant ist ein Arzneistoff, der als Appetitzügler zur Behandlung des Übergewichts eingesetzt wurde, eigentlich allerdings zur Raucherentwöhnung von dem ...

Acomplia (Rimonabant) – Investigational Agent for the ...

Developed by Sanofi-Aventis, Acomplia (rimonabant) is a selective CB1 endocannabinoid receptor antagonist indicated for the treatment of obesity. It works...Read More...

Rimonabanto – Wikipédia, a enciclopédia livre

Rimonabant ou rimonabanto é um fármaco que era utilizado para redução do peso e afinamento da cintura. Em Abril de 2006 o laboratório Sanofi-Aventis anunciou a ...

リモナバン - Wikipedia

リモナバン(リモナバント, 英語: Rimonabant, SR141716)は、選択的な カンナビノイド受容体タイプ1 (英語版) の拮抗薬で ...

Rimonabant - Wikipedia

Il Rimonabant (o SR141716) è un farmaco antiobesità anoressizzante, ritirato dal mercato. Si tratta di un agonista inverso per il recettore CB1 dei cannabinoidi.

Rimonabant — Wikipédia

Le rimonabant (ou SR141716) est un médicament anorexigène contre l'obésité agissant comme un agoniste inverse des récepteurs cannabinoïdes CB1.

Customer Service
1-866-799-3435 (Use ref# 10786) | Contact Form
Copyright © 2018 GlobalPharmacyMeds.to All rights reserved. Disclaimer | Privacy Policy
Accepted Credit Cards and Payment: VISA, MASTERCARD and eCHECK